Abstract: Carcinogenesis involves a growing accumulation of genetic and epigenetic aberrations, leading to the deregulation of cellular homeostasis, followed by neoplastic progression. Although nutritional lipids play a critical role the specific transcriptional mechanisms involved in this process are not completely understood. In this review, we examine the biological effects of dietary essential fatty acids (n-3 and n-6 EFAs) and vitamin A, and the common pathways related to cancer chemoprevention. Eicosanoids (EFAs derivates) and retinoids (vitamin A derivates) are major mediators that act on their corresponding RXR-heterodimerized receptors (PPAR and RAR) and modify the carcinogenetic signalling pathways. Several effects of these mediators, mainly at DNA level, depend on specific molecular properties of the receptor isoforms and their differential affinities for their ligands, whose availability can be intentionally managed through diet. Nevertheless, the previous grade of differentiation in normal development or in cancer cells is an important modulatory factor of the cellular responses, especially when differentiating agents are evaluated. The potential of dietary EFAs and retinoids in chemoprevention and chemotherapy, through their actions on the cellular proliferation and differentiation processes, with particular reference to human breast cancer is discussed herein.
INTRODUCTION
Carcinogenesis is a multistage process, which involves a gradual accumulation of genetic and epigenetic aberrations that ultimately results in the deregulation of cellular homeostasis [1] . Thus, the initiation and progression of the neoplastic process depend on individual susceptibility, which is determined by hereditable characters and their interactions with different environmental factors [2] . Furthermore, nutrition plays a critical role in cancer development and treatment [3] , with there being increasing evidence that some dietary agents, such as phytochemicals (with antioxidant and antiinflammatory properties), essential unsaturated fatty acids, among others, exhibit unique anti-tumour effects that could delay the onset of cancer and thus, serve as chemopreventive agents. Moreover, as many of these agents have selective tumoricidal actions on certain varieties of cancer cells, they may be called chemotherapeutic ones [4] , with experimental and clinical-epidemiological data supporting the use of these compounds in the prevention and control of different epithelial malignancies (colon, lung, prostate, breast, among others). However, specific mechanisms of several of these nutrients/biodrugs, mainly at the transcriptional level, are still not fully understood [5] . In the present work, the interaction of fatty acids and vitamin A-like compounds are analyzed in order to describe common pathways and their potential biomedical implications.
*Address correspondence to this author at the Instituto de Biología Celular (Facultad de Ciencias Médicas, Universidad Nacional de Córdoba), Enrique Barros esq. Enfermera Gordillo Ciudad Universitaria, Córdoba 5014, Argentina; E-mail: aeynard@gmail.com prostacyclin (PGI 2 ). In addition, PGD 2 and PGE 2 can be transformed into PGJ 2 and PGA 2 , respectively, through either non-enzymatic rearrangement or by dehydration. Even though COX enzymes have an elevated affinity for AA (a substrate widely present in foods, such as red meats), when the dietary availability of other 20-C precursors (i.e. EPA) is increased, these enzymes can also be metabolized. Subsequently, the relative levels of dietary precursors affect the levels of the PG formed, which may be deleterious for the body if the level of non-EFAs are abnormally high in the diet [7] .
Other groups of bioactive lipid molecules derive from enzymatic lipoxygenation (LOX) of 20-C unsaturated fatty acids, including leukotrienes (LT) and lipoxins [8] . Furthermore, the cytochrome P450 epoxygenase pathway can generate other compounds, such as the 11, 12-epoxyeicosatrienoic acid, shown in Fig. (1) . Other eicosanoids result from the lipid oxidative metabolism, such as the endocannabinoids (i.e. anandamide, arachidonoylethanol-amide, 2-arachidonoylglycerol), which are endogenous AA metabolites produced in the brain and other tissues that bind and activate the cannabinoid receptors (CB1 and CB2) [9] . These have also been implicated in a wide array of physiological and pathological processes, including cancer, obesity and diabetes [10] .
Effects of Dietary PUFA on Cell Physiology and their Implications in Disease
Dietary essential PUFAs are important precursors for the signaling molecules that control many facets in cell physiology. When quantitatively-altered lipid intake occurs, metabolic perturbations may favour many chronic degenerative diseases (diabetes, obesity, vessel dysfunctions, etc.), and cancer development may also take place [11, 12] . On the other hand, some PUFAs belonging to the n-3 family have chemopreventive properties against prostate cancer [13] . Indeed, it is known that the incidence of many cancers, which differs widely among geographical areas [14] , is related to the relative contribution of various fatty acids to the total dietary intake [15, 16] . Moreover, it is possible to Fig. (1) . Eicosanoid biosynthesis. modify experimentally the plasma membrane phospholipid composition, where pivotal copies of many enzymes are found, by changing the up-stream of the PUFA precursor through lipid intake (i.e. amounts of AA or EPA in foods). Since AA is a precursor of the series 2 of PG and TX, and also of the series 4 of LT, whereas EPA is a precursor of the series 3 and 5, different availabilities of these fatty acids lead to changes in the quantities of their derivates. Thus, the influence of dietary habits is relevant, as fatty acids with 20 carbons play a structural role in all biomembranes. Also, they are substrates for endocannabinoid and eicosanoid formation, with the latter being oxygenated derivates with a wide range of hormonal, pro-inflammatory and regulatory functions [17] .
Eicosanoids participate in carcinogenesis, as they are able to regulate cellular proliferation and differentiation. Nevertheless, they can also act in a bimodal way, as happens for other PUFAs derivates, with it being demonstrated that the blocking of the derivate 5-HETE (hydroxyeicosatetraenoic acid) by the LOX antagonist action consistently induces apoptosis and regulates growth-related signal pathways [18] . On the other hand, the modulation of PPAR (peroxisome proliferating-activating receptors), mainly through the activation of PPAR , should also be taken into account since binding occurs with metabolites formed by alternative 20-carbon PUFA, such as the eicosanoids derived from AA or EPA [18] . COX-derived eicosanoids, such as PGE 2 , induce down-regulation of glycoprotein E-cadherin, a major cell adhesion molecule widely used as a differentiation marker for epithelia-derived cancers [19] , and playing an important role in the development and progression of a wide range of carcinomas [20, 21] . It is well known that in vitro and clinical studies to evaluate malignant cells from skin and other cancer lines suggest that decreased E-cadherin is associated with neoplastic progression [22] .
PUFA-Related Signalling
Dietary essential fatty acids and their eicosanoid derivates are natural ligands of PPAR, which in turn have been implicated in cancer regulation (see Fig. 2 ). These nuclear receptors, first described as being activated by peroxisome proliferators [23] , are represented by three isoforms (PPAR , PPAR and PPAR / ) encoded by different genes. When these bind to their corresponding ligands, they trigger the regulation of important cellular functions, including cell proliferation and differentiation, as well as stress responses. Thus, PPAR are ligand-regulated transcription factors, which control gene expression by binding to specific response elements (PPRE) comprising promoters [24] . The use of synthetic PPAR ligands has allowed the unveiling of many of their potential effects on pathological states, including atherosclerosis, hypertension, inflammation, infertility, demyelination, and cancer [25] .
PPAR deserves special attention, since its activation results in beneficial anti-cancer effects in many cell lines triggered by the release of eicosanoids and fatty acids. Among these, PGJ 2 is a strong endogenous ligand [26] . Also, LA metabolic products, such as 9-HODE (hydroxy- Fig. (2) . Transcriptional activity of dietary lipid derivates. octadecadienoic acid), 13-HODE, and 13-OXO (oxooctadecadienoic acid), are other well-known PPAR ligands [27] . Regarding PPAR 's chemopreventive properties, n-3 fatty acids induce up-regulation of syndecan 1, a glycosaminoglican leading to arrest of the prostate cancer progression [28] . Other examples of anti-tumour PPAR ligands are LA and CLA (conjugated linoleic acid) in colorectal carcinoma, where continuous treatment induces quiescence up to 5-7 weeks after exposition. This effect has also been seen with Ku-7 and DU-145 cells belonging to bladder and prostate cancer cells lines, respectively [29] . Indeed, CLA is a variety of LA with strong anti-cancer activity [30] .
DIETARY VITAMIN A DERIVATES AND ANALOGUES: RETINOIDS AND REXINOIDS

Sources and Metabolism of Retinoids and Rexinoids
Retinoids and rexinoids are chemically related to vitamin A (retinol), an organic compound required as an essential nutrient for humans, even at minimal amounts [31] . Accordingly, naturally-occurring and synthetic derivates are named retinoids, a term coined by Sporn in 1976 [32] . Most recently, the synthetic retinoids have been alternatively called rexinoids, given their high affinity for RXR (retinoid X receptors) [33] . Natural retinoids are mostly represented by retinyl esters, which release retinol by hydrolysis.
In animal organisms, retinal, also known as retinaldehyde, or other closely related compounds, such as 3-hydroxy-retinal, are molecules found in the photoreceptor cells of the retina. These serve as the chromophore of various visual pigments (rhodopsins) [34] . The best described active retinoid metabolites to date are 11-cis-retinal and retinoic acid (RA) isomers (all-trans and 9-cis-retinoic acid). In plants, edible coloured tissues (leaves, fruits, roots) contain dietary pro-vitamin A compounds (carotenoids), which can be converted to vitamin A in animal tissues by oxidative cleavage [35] . The conversion of ß-carotene occurs by two different carotenoidoxygenases, named CMO1 and CMO2, belonging to a family of structurally related non-heme iron oxygenases, with CMO1 being the key enzyme for the conversion of ß-carotene to vitamin A in mammals [36, 37] . CMO1 converts ß-carotene to retinaldehyde by a centric oxidative cleavage at the C15´-C15´ double bond for all varieties of biologically active retinoids, including 11-cisretinal and RA [38] [39] [40] , whereas CMO2 catalyzes an excentric oxidative cleavage of carotenoids (carotene and lycopene) at the C9' and C10' double bonds [39] (Fig. 3) .
The retinol-binding protein (RBP) is the seric transport protein of retinol in the circulation from the liver to its target tissues. The existence of a cell-surface receptor on the target cells, which mediates the uptake of retinol from RBP, has been known since 1975. Recently, this receptor was identified as a trans-membrane protein named STRA6, with its expression being induced by RA in certain cancer cell lines. This molecule was found to be highly specific for RBP, and was identified in those tissues known to require retinol for their functions [40] .
Physiological and Pathological Roles of Dietary Retinoids
Retinol seems to regulate the growth, development, and epithelial maintenance in vertebrates by conversion to the active form, RA [41] . This is an important signaling molecule, which influences developmental processes and cell differentiation by binding nuclear receptors, causing transcriptional regulation of its target genes [42, 43] . Regarding this, the RA mechanism of action is similar to that of steroid and thyroid hormones, involving induction of the expression of specific genes, and thus placing retinoids in the category of hormones, which regulate cytodifferentiation, apoptosis, tissue growth, and embryonic development [44] . Other major physiological processes regulated by RA include vision, reproduction, bone formation, and haematopoiesis.
Since retinoids control cell growth, differentiation and apoptosis, they have become potential chemopreventive and chemotherapeutic agents. Furthermore, they have been shown to suppress carcinogenesis in various organs (e.g. head-neck, skin, bladder, lung, prostate and breast cancers) in animal models [45] . For example, the all-trans RA (ATRA) causes fast terminal differentiation of acute promyelocytic leukemia cells in vitro and in vivo (humans), although unfortunately it is less active in other malignancies. However, clinically retinoids showed promising effects for reversing other pre-malignant human epithelial lesions, and in preventing head and neck, lung, liver and breast tumours [46] . ATRA is also able to regulate the tumour necrosis factor-induced pathway, among others [47, 48] . Moreover, retinoids play a central role in the control of tumour progression, inducing stromal proliferation by regulating the expression of several key molecules, such as matrix metalloproteinases [49] , transforming growth factor-, and also cell cycle-regulating proteins [50] , for example, cyclin dependent kinase I, p16, and p21 [51] .
Retinoid-Related Signalling
The retinoid pleiotropic regulating functions on cell physiology depend on their interaction with two types of nuclear receptors: retinoic acid receptors (RAR) and RXR [52, 53] , which belong to a superfamily of steroid and thyroid hormone receptors [54] . Each receptor (RAR and RXR) has three subtypes ( , and ). Also, each subtype can possess some isoforms which differ physiologically [55] . For example, RAR has four isoforms with distinct retinoid affinities and different biological functions. The loss of RAR 2 is associated with tumorigenesis and retinoid resistance, whereas its induction prevents this carcinogenetic condition. On the other hand, the expression of RAR 4 is increased in various types of cancers. In fact, its over-expression in transgenic rodents causes hyperplasias and neoplasias in various tissues, whereas its induction increases proliferation of certain tumour cells which do not express RAR 2 [56] .
RA possesses a dual role in carcinogenesis, hence precluding a modulating, homeostatic capability. When it binds to RAR, neoplastic growth is inhibited, whereas if it activates the nuclear receptor PPAR / , stimulation of cell growth and inhibition of apoptosis are the results. The choice of the target receptor seems to be determined at the cytosol environment by the differential transport systems required for nuclear location. Before RAR recognition, the cellular RA-binding protein II (CRABP II) operates as the carrier, while the fatty acid-binding protein 5 is necessary for PPAR / ligation [57] . There are two CRABPs (I and II), both belonging to the highly-conserved family of small cytosolic lipid binding proteins. CRABP I retains RA in the cytoplasm and prevents its nuclear uptake, hence working to modulate the balance system, with CRABP II being overexpressed in a wide variety of cancers, such as neuroblastoma and Wilms' tumour [58] . In the nucleus, RAR binds retinoids, ATRA and the closely-related isomer 9-cis-RA. RXR binds 9-cis and all-trans isomers of RA and rexinoids [59] [60] [61] .
Both in vitro and in vivo studies have revealed that several nuclear receptors need to constitute a heterodimer with RXR in order to exert transcriptional functions. The first identified heterodimeric partners were the receptors for thyroid hormones, retinoids, and vitamin D. The PPAR, liver X receptors, farnesoid X receptor, pregnane X receptor, and constitutively activated receptors are also included in this group [60] . All three RXR subtypes are common heterodimerization partners for members of the so-called subfamily 1 nuclear receptors. They exert their actions as liganddependent transcriptional regulators by binding to the specific DNA-response elements found in the promoter region of target genes, whose interaction with RXR increases with their DNA-binding efficiency [61] . ATRA, for example, activates RAR/RXR heterodimers and exerts its biological actions by binding to retinoic acid response elements (RARE) [62] . The CRABP II combined with RA acts as a co-activator for RAR/RXR, interacting specifically with the receptor complex RAR/RXR, which is bound to the RARE of particular genes in order to greatly activate their expression [63] . In addition, retinoids can either activate or repress gene expression through RAR/RXR heterodimers interacting with other transcription factors, such as AP-1, estrogen receptor , and nuclear factor NF- [64] .
PATHWAY INTERACTIONS: CO-MODULATION OF PPAR/RXR AND RAR/RXR SIGNALLING BY DIETARY PUFA DERIVATES EICOSANOIDS AND RETINOIDS
The transcriptional activity of eicosanoids is mediated by ligation with PPAR, which act in their corresponding PPRE. The retinoid transcriptional activity is carried out by RA (the active form), which binds to RAR in order to interact with their corresponding RARE. Nevertheless, RA also possesses other complementary actions. It binds to RXR, which in turns activates either PPAR or RAR by heterodimerization. Moreover, RA can bind directly to PPAR. Consequently, RA is able to modulate gene expression directly by ligation with PPAR or RAR, and indirectly by binding with RXR (complexes PPAR/RXR and RAR/RXR). Concomitantly, eicosanoid-related regulation can be modified by RAmediated co-modulation. As mentioned above, the availability of these lipid mediators can be changed in a quailtative-quantitative manner by dietary PUFAs supply.
Interestingly, there is a regulatory link between carotenoids/pro-vitamin A and fatty acid metabolism, with it being reported that the CMO1 gene can be transcriptionally regulated by the action of PPAR/RXR, either in mice or in humans [65] . Furthermore, our work on two varieties of human breast cancer cells adds further support to the significant interrelation existing between PUFA (n-3: EPA; n-6: GLA --linolenic acid-) and ATRA administered in the culture media, with the differential responses (Quiroga et al., unpublished data). Thus, as shown in Table 1 , we can observe that for the lines ZR-75-1 and MCF-7 (which exhibit dissimilar grades of differentiation [66] ), COX activity (marker: release levels of 12-HHT) predominates over LOX activity (marker: release levels of 12-HETE). ATRA increases eicosanoid formation (COX and LOX pathways) in ZR-75-1 (undifferentiated line with low basal levels of eicosanoids), but it strongly reduces this synthesis in MCF-7 (the more differentiated line exhibiting the upper basal levels of eicosanoids). When ATRA is co-administered with GLA, the retinoic effects on LOX activity are suppressed. On the other hand, co-treatment with EPA decreases COX activity in both lines, independently of the ATRA effect. The ZR-75-1 cells treated with ATRA+GLA produce higher 12-HETE than cells treated with ATRA+EPA, whereas the inverse is true for MCF-7 cells.
Our results agree with previous ones showing that the combination of certain dietary PUFA and retinoids consistently inhibited the progression of mammary carcinogenesis in both cell cultures and animal studies, prompting future research to clarify these findings [67] . In another work, the combination of RXR and PPAR synthetic agonists (bexarotene and rosiglitazone, respectively) in the treatment of colon cancer produced a greater efficacy in growth inhibition than either single agent. Also, co-treatment cooperatively decreases COX-2 expression and PGE 2 synthesis, increasing the desirable expression of the differentiation markers [68] .
CONCLUSIONS
In the framework of the available data, the outcome of a nutritional intervention with two types of molecules (derivates of fatty acids and vitamin A) may implicate interactions of major molecular pathways, involving the regulation of critical common points in cell proliferation, differentiation and death. Thus, the chemopreventive and anti-cancer activities of these compounds depend on synergic effects at the transcriptional level. Nevertheless, the previous grade of differentiation of the tumour tissue should be considered, since it is a pre-condition for cellular responses, especially when cytoprotective and cytodifferentiating agents are evaluated. Overall, the neoplastic phenotype will be determined by the existing interplay between the different pathways. Regarding this, the sum of the effects will depend on their DNA binding sites and on the specific molecular properties of the receptor isoforms and their differential affinities for dietary ligands, whose availability in foods and meals may be intentionally-managed.
Taken together, the evidence suggests that EFAs and retinoids, as natural dietary compounds, possess an important biomedical potential, with chemoprevention and chemotherapy being the main aims, given their regulating activities on cellular proliferation and differentiation. Also, the nutrigenomic study of different receptors for dietary ligands will promote future nutritional, clinical and epidemiological approaches.
Since curcumin, a polyphenol extracted from the rhizomes of Curcuma longa L. (Zingiberaceae), has been proposed for breast cancer chemoprevention, the aim of the present work was to determine if it had anti-tumour effects on mammary cells which are resistant to oxidative damage. ZR-75-1 cells were treated with curcumin and copper(II) sulphate in order to evaluate cell death and γ-glutamyltranspeptidase (GGTP) activity. Curcumin was cytotoxic in a dosedependent manner (loss of viability with lactatedehydrogenase release) with apoptotic effects on ZR-75-1 cells. Also, curcumin displayed an antioxidant effect only on the copper-oxidized cells. The GGTP activity was decreased in a dose-dependent manner by curcumin, with the changes in this parameter accounting for neoplastic inhibition (direct relation between the enzyme activity and cellular viability). Summing up, our results suggest that curcumin induced apoptosis in ZR-75-1 with an antioxidant activity performed on those treated with copper(II) sulphate, which should be explored more thoroughly with the involvement of the GGTP enzyme activity as biomarker of their malignancy.
INTRODUCTION
Breast cancer is one of the most frequent causes of female death worldwide, with its pharmacological treatment being a medical challenge due to its malignancy (1) . Regarding this, curcuminoids have been proposed as potential anti-tumour agents for refractory cases (2, 3) . Thus, the effects of curcumin, a polyphenolic antioxidant extracted from the rhizomes of Curcuma longa L. (Zingiberaceae), need to be evaluated in human aggressive cancer cells, such as the line ZR-75-1.
With regard to preventive strategies, the use of dietary antioxidants has been proposed to counteract the damages induced by oxidative stress (4). Several studies have been directed towards the evaluation of biomedical properties of different plant biomolecules which might be nutraceutical (5) . Concerning the potential of these substances, one of the most pursued is the anti-tumour activity acting at different carcinogenetic stages (6) . From many phytochemicals, the curcumin was proposed as a chemopreventive and chemotherapeutic agent in breast cancer (7) . Related to this, curcumin could inhibit cancer initiation, promotion, progression and dissemination in animal models (8) . However, given its antioxidant activity, the effects †Financial support: Secretaría de Ciencia y Tecnología, Universidad Nac. Córdoba. may differ depending on the cellular redox state. Consequently, in vitro probes should be used in cells challenged with an oxidant agent, such as copper(II) sulphate. Also the xenobiotics (i.e. curcumin and cupric salts), which form part of human diet, could modulate different cellular parameters such as the membrane γ-glutamyltranspeptidase (GGTP), which is involved in cellular antioxidant defence (9) . Therefore, GGTP modulation could be considered in oncological interventions, as it may have an active role in cellular proliferation and malignant behaviour (10) .
The aim of the present work was to determine the curcumin anti-tumour effect on ZR-75-1 cells, which can resist usual oxidative therapy, by assessing cell death and GGTP activity. 
MATERIALS AND METHODS
Chemicals
Cell culture and treatments
The human breast cancer cell line ZR-75-1 (American Type Culture Collection) was cultured in RPMI-1640 completed with 10% foetal bovine serum (FBS), 100 U/mL penicillin G and 40 µg/mL gentamycin sulphate, incubated at 37ºC in a 5% CO2 atmosphere. After 24 h post-seeding in 96-well plates (30,000 cells/ well), cells were incubated for 24 h in medium containing curcumin (0,5,10,20 and 40 µM, dissolved in dimethylsulphoxide (DMSO, at a final concentration below 0.05% in the media) with cupric sulphate (0,2.5 and 10 µM, dissolved in water). The dose range of curcumin used for experiments were chosen in accordance to other researchers in other to modulate molecular targets of malignant development (11) , while the copper concentrations were those required for in vitro protein oxidation (12) .
Cellular viability assessment
After treatment and discarding the media, viable cells were cultured with 60 µL MTT (0.25% in culture media without phenol red) for 4 h. After washing with PBS, the stained cells were solubilized with 100 µL Triton X-100 (10%, 20 min). Results were recorded using a BioRad 680 microplate reader and the relative absorbance was calculated (percentage with respect to Control) at 540 nm (13) .
LDH activity measurement
Technical requirements were first established to avoid interferences in the study of this enzyme for the experimental conditions of this work. The released LDH by death cells was measured following the LDH-P UV AA kit manufacturer's instructions, and results (IU/L converted to percentages) were recorded at 340 nm (14) .
Cytological characterization
Cells were first stained with 1µg/mL of Hoechst 33342 (15 min at 37ºC in darkness). After washing three times with PBS, the vital/death phenotype was determined using a fluorescence microscope (Axiovert 100, Zeiss) under UV light (365/380 nm). Images were analysed using the Axio-Vision software (Zeiss) (15) .
GGTP activity measurement
After the medium was discarded, the active enzyme was released from the cellular membranes using 20 µL of Triton X-100 (10%, 20 min). Then, GGT was measured following the γ-G-test kinetic AA kit manufacturer's instructions, adapted to determinations in cultured cells (10) . Proteins were measured in 10 µL of the samples by the Bradford method (16) , in order to report results as mIU/mg of protein (specific activity).
Free radical detection
After the treatments, plates were washed three times with PBS, and cells were lysed with 15 µL of sodium dodecylsulphate (1%, 20 min). 5 µL of the samples were separated for protein determination by the Lowry method (17) . Samples (10 µL) were mixed with 50 µL of 16 mM TMPD, incubated for 30 min and measured at 540 nm. Given the high susceptibility of TMPD to oxidizing agents (4), it was prepared in DMSO in order to stabilize solutions and improve the technical efficiency. The presence of reactive oxygen species (ROS) was calculated by a calibration curve, with results being reported as µM of H2O2/mg of proteins.
Statistical analysis
Data were expressed as means ± standard error (SE) from four separate experiments performed in triplicate. ANOVA models were used to evaluate differences among the treatments. For the comparison of means, Tukey tests were used (p<0.01). Associations between different cellular responses were established by the Pearson coefficient. The statistical analyses probes were performed using the InfoStat 2008e.1 software.
RESULTS
Cellular death
The percentage of viable cells respect to controls was significantly decreased by curcumin in a dosedependent manner (p < 0.0001), with non-copper(II) sulphate-related effects present on this variable (Table) . In order to confirm cell toxicity, the LDH activity in the culture media was assayed. A strong inverse correlation between this variable and the decreasing cellular viability (Pearson coefficient=-0.70) was found. In a dosedependent manner, curcumin increased the LDH release from injured cells (p < 0.0001). Although this effect was more notable in cells treated with 10 µM copper (II) sulphate, this salt did not modify the enzyme release (Table ) . Morphologically, cultures with decreased cellular viability exhibited several apoptotic figures (Figure) .
Specific GGTP activity and its correlation with cellular viability
In order to establish the value of this parameter as a breast cancer biomarker, it was necessary to decide an appropriate experimental cell density. Regarding this, a number of 30,000 cells per well was chosen after performing experiments on a wide range of seeded cells (10,000-70,000 cells/well). A direct correlation was found between the specific GGTP activity and the cellular viability assessed by the MTT assay (Pearson coefficient=0.68). Concerning this, curcumin was able to diminish the enzymatic activity dose-dependently, which was enhanced by incorporation of copper (II) sulphate (p < 0.0001); (Table) .
Free radical level
The cellular oxidative level was significantly increased by copper (II) sulphate at both concentrations (2.5 and 10 µM). Curcumin behaved as an antioxidant agent under copper-related oxidative stress (p < 0.0001), with effects being clearer in cells treated with 10 µM of copper (II) sulphate, and absent in copper-unexposed cells (Table) . 
DISCUSSION
Dietary polyphenols, such as curcumin, could be considered for cancer chemoprevention, which can be primary (preventing illness appearance) and/or secondary (preventing illness progression), and for therapeutic schemes (chemotherapy and chemoadjutancy) (18) . In the present study, curcumin was found to be cytotoxic for ZR-75-1 cells in a dose-dependent manner, despite the fact that it retained its antioxidant activity on copper-oxidized cells. These results indicate that cell death was induced by mechanisms different from oxidative damage (19) , with the role of thiol-reactive metal ions requiring further studies due to the existence of contradictory data (20) . Nonetheless it was previously established that curcumin induced apoptosis on the human breast cancer line MCF-7 (21), the ZR-75-1 cell line was used because it represents a clear example of cells which can tolerate traditional anticancer oxidative stress-based treatments. Moreover, the viability of this cell line was not compromised by copper-induced peroxide formation. This finding show that these cells resist different kinds of oxidizing agents, such as arsenic and other xenobiotics reported by Soria et al. (10) .
Concerning curcumin molecular targets (22) , an incipient theory sustains that neoplastic cells have deregulated pathways triggered during cancer initiation and promotion, which are essential for tumour development, such as the GGTP activity. As a result, their inhibition by antioxidants may lead to cellular death (23, 24) . Also, curcumin can activate the steroid/ xenobiotic receptor, which is antiproliferative in breast cancer cells, including ZR-75-1 (25) . Regarding this, given the indirect relation between cellular viability and LDH release, we conclude that curcumin was cytotoxic for ZR-75-1 cells leading them to acquire apoptotic features.
Related to cancer development and pathologicallyactivated antioxidant defences, the GGTP activity has been proposed as a tumour biomarker due to its cytoprotective and pro-proliferating activities (26) . Moreover, it was shown to be a sensitive variable with respect to culture conditions (i.e. cellular density), with a strong direct relation being found between the enzyme activity and ZR-75-1 viability, thus supporting its biological role in malignant behaviour. Furthermore, curcumin decreased the GGTP activity (firstly described finding) and compromised the tumour viability. In this regard, the impairment of this antioxidant enzyme may lead to cell death by down-regulation of enzyme-related protumour pathways (27, 28) . In this regard, it is important to keep in mind that this parameter depends on the cytodifferentiation grade for several dietary compounds, showing a direct relation with the viability of undifferentiated cells (i.e. ZR-75-1), whereas other more differentiated types (i.e. MCF-7) exhibit an inverse relation (10; Quiroga et al., unpublished data), with further studies involving a wide range of tumour cell types being encouraged. 
CONCLUSIONS
Introduction
Arsenic has been proposed as a chemotherapeutic agent for human leukemia and other solid tumors (Ling et al., 2002) . On the other hand, its chronic exposure has been linked epidemiologically with an elevated risk of urinary, lung, skin, colon, and liver carcinomas, in areas with high levels of arsenic in the drinking water (Paoloni et al., 2005) . Oxidative stress is being increasingly recognized as a possible mechanism implicated in both induced-arsenic apoptosis and carcinogenicity (Shi et al., 2004; . Consequently, the potential of several antioxidants to counteract arsenic injury has been tested in vitro and in vivo (Wei et al., 2005; . Silymarin and quercetin are polyphenolic antioxidant flavonoids, which possess cytoprotective and anticarcinogenic effects, and are widely found in vegetable sources (Volate et al., 2005) . These compounds are usually presented as equivalent (Khanna et al., 2007) . However, this is not always the case. Regarding this, quercetin is a more powerful antioxidant than silymarin against the dose-dependent cytotoxicity of hydrogen peroxide (Svobodova et al., 2006) . Also, the former is a non-competitive inhibitor of arylamine N-acetyltransferase 1 and 2 enzymes in the metabolic activation of aromatic and heterocyclic amines, whereas silymarin is not (Kukongviriyapan et al., 2006) . Due to their similarities and differences, they could play distinct roles in antineoplastic chemotherapy (Kanadaswami et al., 2005) . Therefore, it is important to acquire further knowledge about the interactions among arsenite and antioxidant flavonoids in cancer and normal cells.
Cellular membrane integrity plays a critical role in cell functionality and viability, which is relevant in carcinogenesis and oncological pharmacology (Hossain et al., 2000; . In this regard, the lipid sialylation and the ectoenzyme γ-glutamyltranspeptidase activity (GGT, CD-224, EC 2.3.2.2) were studied as markers of the cell membrane status. Gangliosides (sialylglicolipids) have previously been found to be involved in cellular surface-related regulation and in biomembrane resistance to oxidation (Proia, 2003; Sergent et al., 2005) . Furthermore, since some cancer cells present aberrant glycosilation, with the sialic acid content (SA) being a useful tumor marker (Narayanan, 1994) . Finally, GGT protects cells from oxidative stress with constitutive high enzyme levels, being associated with cancer development and chemoresistance (Hanigan et al., 1999) . In conclusion, the aim of this work was to study the arsenite-flavonoid interactions and their effect on some properties of membrane components, and also on the viability of human mammary cancer cells. (Engel and Young, 1978) , were cultured in Dulbecco's modified Eagle's medium completed with 10% fetal bovine serum (FBS), 100 IU/mL penicillin G and 40 μg/mL gentamycin sulphate, incubated at 37°C in a 5% CO 2 atmosphere.
Materials and methods
Chemicals
Treatments
After 48 h post-seeding (40,000 cells/cm 2 ), cells were incubated under all of the following conditions (acute treatment): 200 μM NaAsO 2 (As), 5 μM silymarin (S), 50 μM quercetin (Q), 200 μM NaAsO2 plus 5 μM silymarin (As + S), 200 μM NaAsO2 plus 50 μM quercetin (As + Q), and controls having no treatment (C). Flavonoid concentrations were used in agreement with the oral bioavailability obtained in clinical assays at high doses, (Williamson and Manach, 2005) . Treatments were continued for 0-8 h in order to evaluate cellular viability, while other variables were studied after a 2 h exposure. Additionally, GGT activity was also measured after treatment and allowed to recover for 2 h in free treatment medium. Consequently, cells could be obtained both with (RC) or without recovery (NRC).
Crystal violet staining (cellular viability)
After 48 h attachment in 96-well plates (10,000 cells/well), viable cells were stained with 0.5% crystal violet in 50% methanol for 15 min. After washing with 50% methanol three times, the stained cells were solubilized with 20% methanol in a sodium citrate solution (0.1 M, pH 5.4). Results, consistent with cellular density, were recorded by a BioRad 680 microplate reader and presented for relative absorbance (percentage calculated with respect to C) at 570 nm.
Membrane obtention
After enzymatic harvesting with porcine trypsin, cells were homogenized at 20,000 rpm for 30 seconds in 1 mL of 10 mM HEPES buffer (pH 7.4, containing 2 μg/mL leupeptin and 1 mM EDTA). They were centrifuged at 100,000 g for 1 h at 4°C to recover the pellet (P), which was then resuspended in 200 μL of 10 mM HEPES buffer. The protein content was determined according to the Lowry method, and each P suspension (150 μL) was mixed with 750 μL chloroform/ methanol (2:1 v/v, Fölch extraction). The mixture was centrifuged at 1,000 g for 10 min, and then the upper layer was used for sialic acid determination. The lower layer was washed twice with chloroform/methanol/water (3:48:47 v/v/v) and dried under a pure nitrogen flow at room temperature. Lipids were resolubilized in 200 μL ethanol (eP samples).
GGT activity measurement
The modified Szasz method was used following the γ-G-test kinetic AA kit manufacturer's instructions (Szasz, 1969) . Samples were mixed with 1% Triton X-100 and 100 mM TrisHCl substrate buffer pH 8.5 (containing 2.9 mM L-γ-glutamyl-3-carboxi-4-nitroanilide and 100 mM GLY-GLY) in the proportion 1:1:9 (v/v/v). Then, the absorbance at 405 nm was recorded. Results were expressed in mIU/mg of proteins (1 IU = 1 μmole of product/min at pH 8.5 and 25°C). After sample solubilization with Triton X-100, the enzyme activity was recorded for 24 h, using different sample concentrations (protein amount) and the substrate buffer alone as blank. Concerning this, activity was recorded for 10 min in samples containing 1.5 mg/mL of protein.
SA content measurement (membrane sialylation)
After Fölch extraction, the SA content (nmole/mg of protein) was measured in the upper phase at 580 nm according to Miettinen and Takki-Luukkainen (1959).
Membrane oxidation assessment
The conjugated dienes (CD) were measured as lipid oxidation markers under low-temperature conditions in eP samples at 234 nm against ethanol (Recknagel and Glende, 1984) . Results (DO/mg of protein) were expressed as relative absorbance compared to controls.
Free radical activity was detected by the oxidized TMPD radical measurement (Cornelli et al., 2001) . Briefly, each eP sample was mixed with 2 mM TMPD in ethanol (1:1 v/v), and kept in an oxygen-free environment at room temperature for 30 min. Results (DO/mg of protein) were recorded at 560 nm and expressed as relative absorbance compared to controls.
Statistical analysis
Data were expressed as mean ± standard deviation (SD) from four separate experiments performed in triplicate, unless otherwise noted. ANOVA models were used to evaluate differences of cellular viability and membrane parameters (GGT and SA) among treatments (C, S, Q, As, As + S, As + Q). For the comparison of means, Tukey tests were used, considering a significance level of α = 0.05. The paired tstudent test was used to compare GGT activity in the NRC and RC (p-values b 0.05). The association between these variables was determined using the correlation coefficient (CC), while the time-related cellular viability was assessed by single linear regression. Analytical probes were performed using the InfoStat 2007e.1 software.
Results
Cellular viability
The studied human breast lines exhibited different susceptibilities to the treatments (Table 1) , with the following treatments decreasing cellular viability significantly in a timedependent way: As, As + S and As + Q on ZR-75-1 cells, and As and As + S on MCF-7 cells.
GGT activity
The specific activity of GGT, depicted in Fig. 1 , had quantifiable basal values in both breast cancer lines, although MCF-7 cells exhibited significant lower activity than ZR-75-1 cells (p b 0.05) under the different experimental conditions. It was done with different comparisons in order to analyze the enzyme data:
• GGT activity before recovery. MCF-7 cells did not response to the 2-hour treatments. On the other hand, the enzymatic activity was increased in ZR-75-1 cells by exposure to flavonoids with respect to control, although quercetin had the strongest effect (p b 0.05), while As, As + S and As + Q had non-significant lower activities than control (p b 0.09).
• GGT activity after recovery. MCF-7 cells treated with S, As, As + S and As + Q increased the GGT activity with respect to control (p b 0.05). A decreased activity was seen with the Q treatment (4.4 fold lower; p b 0.02) when NRC and RC results were compared, whereas it was increased after As exposure (2.1 fold higher; p b 0.05). ZR-75-1 cells treated with As and As + S had significant lower activities than control (p b 0.05). Additionally, an increased GGT activity was found in C, S, As, As + S and As + Q treatments when NRC and RC results were compared: 3.6, 2.4, 3.8, 5.1 and 5.7 folds, respectively (p b 0.05).
Membrane sialylation
Despite the fact that ZR-75-1 and MCF-7 cells had similar basal levels of SA in their membranes (288.8 ± 36 and 232.2 ± 36 pmoles of SA/mg of proteins, respectively), they responded by different extents, being the SA content in MCF-7 lower than in ZR-75-1 under the five treatments (p b 0.05): 3.4 fold (S), 18.9 fold (Q), 8.8 fold (As), 7.4 fold (As + S) and 4.1 fold (As + Q). In regard to As, S, Q and As + S treatments, they decreased SA amounts with respect to control only in MCF-7 cells, while As + Q treatment increased the membrane SA content independently of the tumor line (p b 0.05) (Fig. 2) . Cells were incubated under the following conditions: none (C), 5 μM silymarin (S), 50 μM quercetin (Q), 200 μM sodium arsenite (As), As + S and As + Q. Data are expressed as% of controls (mean ± SD). ↓Significant decrease compared with the corresponding untreated controls at each time (p b 0.05).
Membrane oxidation and its relation with other parameters
In ZR-75-1 cells, the CD levels were similar: 100 ± 0 (C), 112 ± 9.8 (S), 126 ± 16.7 (Q), 121 ± 26.1 (As), 113 ± 23.6 (As + S), and 95 ± 26 (As + Q). S, Q and As + Q treatments decreased TMPD measures b 5% of control (p b 0.03), while As + S reduced them by 50%. Subsequently, the TMPD oxidation was not strongly related to CD formation (CC b 0.5). In MCF-7 cells, the CD levels were also similar: 100 ± 0 (C), 102 ± 5.6 (S), 96 ± 8.4 (Q), 95 ± 11.4 (As), 99 ± 15.9 (As + S), and 85 ± 20 (As + Q). In contrast to ZR-75-1 cells, the TMPD oxidation was reduced by the treatments to some extent and this was closely related to CD formation (CC N 0.5). In both breast lines, the CD elevation enclosed upper GGT activity (CC N 0.5). Although this enzyme and the SA content had a non-linear relationship, both were linked with decreased TMPD data (CC b −0.5). Moreover, increased SA content was associated with lower CD formation (CC b −0.5).
Discussion
The malignant behavior of breast cancer cells is closely linked to their membrane properties. In the present work, the different lines were treated following a previous protocol . Accordingly, CHO-K1 cells needed a recovery time in order to show quantifiable amounts of Hsp70 and GGT, indicating a low or absent constitutive presence. The arsenite-induced stress produced increases in GGT (1.73 fold), CD (1.85 fold) and Hsp70 (3.79 fold), which were counteracted by flavonoids.
Since ZR-75-1 and MCF-7 cells, together with other lines positive for estrogen receptors (ER+), share substantial global similarities in the phenotypic characteristics and in the structures of their respective transcriptomes with human ER + breast tumors, these lines are good experimental models in which to identify events that are likely to be important in these cancers (Zhu et al., 2006) . Nonetheless, in the presence of breast cancer heterogeneity, some biomedical relevant differences can be found. Indeed, ZR-75-1 cells are selectively insensitive to the antiproliferative actions of 2-methoxyestradiol due to their high levels of 17-β-HO-steroid dehydrogenase II, which rapidly inactivate the steroid (Liu et al., 2005) . Furthermore, ZR-75-1 and MCF-7 lines reflect dissimilar grades of differentiation, as the latter retains several characteristics of differentiated epithelium (Engel and Young, 1978) . Here, these differences were supported by the fact that the ZR-75-1 cells showed an elevated constitutive GGT activity, an extended SA induction and a weaker response to the trophic effect of a phytoestrogen (i. induced toxicity on ZR-75-1 cells was not prevented by either flavonoid, while quercetin protected the MCF-7 cells for 8 h.
With regard to the GGT, which is constitutively present in several tumors (Hanigan et al., 1999) , both breast lines exhibited detectable basal levels. Since the enzymatic activity of GGT in ZR-75-1 was increased in RC with respect to NRC including controls, the change of culture medium resulted in a self-sufficient stress condition. This phenomenon was not seen in quercetin treated cells, which had a significant rise after the first 2 h of treatment (2.73 fold), but without showing any variation after the medium change. Since GGT expression is regulated by the cytosolic glutathione pool and steroids (Rasmussen et al., 2005; Chinta et al., 2006) , we speculated that the increased quercetin-induced activity might generate enough intracellular glutathione to sustain the enzymatic activity level reached during the recovery time. Conversely, although silymarin increased GGT activity 1.76 fold, it did not protect cells from the medium change-related stress. In arsenitetreated cells, only quercetin protected cells from the arseniteinduced inhibition of GGT, requiring at least 2 h of recovery. In MCF-7 cells, the enzyme was less activated by stressors (medium change or treatments) with a low basal GGT activity (respect to ZR-75-1 cells). Arsenite increased it after the recovery time, and this was not diminished by either quercetin or silymarin.
In the upper phase of the Fölch partition from extra-neural sources, the sialic acid (SA) content represents essentially monosialylated gangliosides from the plasma membrane surface (Hammache et al., 1999) . Related to this, ZR-75-1 cells had a greater SA value than MCF-7 cells, with As + Q treatment increasing it for both lines, whereas As, S, Q and As + S treatments reduced the SA content only in the MCF-7 line. Although SA content was not related to cell viability in this work, its pharmacological regulation could be important, since ganglioside molecular interactions are important in cancer growth due to their role in the immune response and in the metastatic process (Hakomori, 2002; Varki and Varki, 2007) .
The GGT activity and the SA content were chosen as membrane markers with reference to our previous results, since they were susceptible to prolonged arsenite exposure in the CHO-K1 cells, showing increased GGT activity and decreased SA content (Bongiovanni, 2006; . This line is usually used as a non-tumoral referent and its responses are compared with human cancer cells (Ling et al., 2002) . Moreover, these cells are positive for estrogen receptors and have a similar SA content to the breast cells studied (Nethrapalli et al., 2005; Bongiovanni, 2006) . Since the inadequate sialylation and the sustained activation of GGT are tumoral factors (Narayanan, 1994; Hanigan et al., 1999) , they should be taken in account in the carcinogenetic compound prospecting.
Concerning lipo-oxidation, distinct lipid sensitivities were found between ZR-75-1 and MCF-7 cells (different TMPD-CD correlation coefficients). The regulation of the GGT activity and the sialylglycolipid content may modulate the membrane resistance to oxidation, leading to a decrease in free radical activity and CD formation. Since the GGT kinetics and redox status can be modulated by changes in membrane lipid composition (Medina Basso et al., 2006), the quercetin and silymarin effects on arsenite-treated cells may also respond to the differential flavonoid affinity for the lipid bilayer. Moreover, the weak relation between cellular viability and oxidative responses involves non-unidirectional mechanisms converging in both arsenite and antioxidant actions (Piga et al., 2007) .
Conclusion
Taken together, our results show that there were differences between breast adenocarcinoma lines, which must be taken into account when extrapolations are made. Regarding the flavonoids studied, which protect non-tumoral cells from arseniteinduced stress , silymarin should be considered in clinical investigations as an adjuvant agent in chemotherapy. However, the use of quercetin should be carefully evaluated in women under oncological management, since this flavonoid increased the GGT and SA levels, which have been considered tumor markers. Furthermore, quercetin could interfere with the arsenite toxicity in therapeutic approaches. mirtavalentich@gmail.com RESUMEN La curcumina, diferuloilmetano, 1,7-bis-(4-hidroxi-3-metoxi fenil)-hepta-1,6-dieno-3,5-diona, es un compuesto polifenólico, que se extrae de los rizomas de la Curcuma Ionga a los que le da el color amarillo característico y ha sido utilizado como aditivo alimenticio. Posee actividad antiinflamatoria, antioxidativa, pro-apoptótica, antitumoral y anticancerosa. La gama glutamiltranspeptidasa (GGTP) es una enzima de membrana que metaboliza el glutation, molécula con elevada capacidad antioxidativa. Es marcadora de estrés celular y de algunos cánceres. Valoramos el efecto de la curcumina, en células ZR-75-1 con o sin la adición de Sulfato de Cobre, un agente oxidativo, sobre la proliferación, la actividad de la enzima GGTP, y la visualización de la apoptosis. La proliferación celular disminuye significativamente con el tratamiento con curcumina (20 y 40 µM) pero no es afectada significativamente con la adición de Sulfato de Cobre (2.5 y 10 µM). La curcumina (5 y 10 µM) disminuye la actividad específica de la enzima GGTP presentando un comportamiento bifásico con un punto de inflexión a los 20 µM de curcumina e incrementando a la concentración de 40 µM. La adición de 2.5 μM de Sulfato de Cobre no modificó el efecto de la curcumina sin embargo 10 μM de Sulfato de Cobre provocó un efecto aditivo en la disminución de la actividad de la enzima GGTP. Se observaron figuras apoptóticas ante el tratamiento con curcumina con y sin el agregado de Sulfato de Cobre. La curcumina indujo apoptosis y afectó la proliferación de células ZR-75-1 y en forma bi-fásica la enzima GGTP lo cual fue potenciado con Sulfato de Cobre (10 μM). PALABRAS CLAVES curcumina, quimioprevención, carcinogénesis. ABSTRACT The curcumine, diferuloylmetane, 1,7-bis-(4-hidroxy-3-methoxy fenil)-hepta-1,6-diene-3,5-dione, is a polyphenolic compound that is extracted of the rhizomes of the Curcuma Ionga to those that it gives the characteristic yellow color and that it has been used as food additive. It has antiinflammatory, antioxidative, pro-apoptotic, antitumoral and anticancer activity. The gamma glutamyltranspeptidase (GGTP) is a membrane enzyme that metabolizes the glutathion, molecule which has a high antioxidative capacity. It is a marker of cellular stress and of some cancers. We added curcumine (0, 5, 10, 20, 40 μM) on cultured ZR-75-1 cancer cells with or without Copper Sulfate (2.5-10 μM) during 24hs and measured the cellular proliferation, the activity of the enzyme GGTP and visualized the induction of apoptosis. The cellular proliferation diminishes significantly with the curcumine treatment (20 and 40 μM) but it is not affected significantly with the addition of Copper Sulfate (2.5 and 10 μM). Curcumine (5 and 10 μM) decreased the GGTP activity with a biphasic behavior with an inflexion point at 20 μM of curcumine and increasing at 40 μM. The adittion of 2.5 μM Copper Sulfate did not modified the curcumine effect. However, 10 μM of Copper Sulfate, induced an additive effect on the diminished activity of the GGTP. It is observed apoptotic figures before the treatment with curcumine with and without the adittion of Sulfate of Copper. Curcumine induced apoptosis and affected the proliferation of ZR-75-1 cells and GGTP activity in bi-phasic form and it had an additive effect with Copper Sulfate (10 μM).
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INTRODUCCIÓN
La curcumina, 1,7-bis-(4-hidroxi-3-metoxi fenil)-hepta-1,6-dieno-3,5-diona, es un compuesto polifenólico, que se extrae de los rizomas de la Curcuma Ionga. Esta asociada a la prevención de lipoperoxidación y disminución del estrés oxidativo por su acción antioxidante (Rajagopalan & Kallikat, 2004). Inhibe la actividad del factor de transcripción NF-KB induciendo la apoptosis y por ende, inhibiendo el desarrollo tumoral (Braiteh & Kurzrock, 2005) . La curcumina (fitoquímico, antioxidante) y el cobre (en forma de sal, oxidante) son agentes que se ingieren con la dieta y pueden afectar la enzima gama glutamiltranspeptidasa (GGTP) vinculada al metabolismo celular del glutatión, un importante reductor celular (Rukkumani, 2004 ) y es activada por estrés oxidativo (Kugelman et al, 1994) . Su actividad ha sido referida como un factor de reconstitución de defensas celulares oxidantes / antioxidantes afectando el proceso de carcinogénesis por la activación del factor de transcripción NF-kappaB (Cremonezzi et al, 2001 ) Los objetivos son valorar el efecto de la curcumina y/o Sulfato de Cobre sobre la actividad de la enzima gama glutamiltranspeptidasa (GGTP), la proliferación celular y la apoptosis.
MATERIALES Y MÉTODOS
Los reactivos se obtuvieron de Wienner y Sigma Chemical Co. La línea celular ZR-75-1, de la American Type Cell Collection. Las células cultivadas en medio DMEM completo, fueron tratadas durante 24 horas, con curcumina (0, 5, 10, 20 y 40 µM) en ausencia / presencia de Sulfato de Cobre (2.5 y 10 µM). Se determinó la proliferación celular con el colorante MTT según Li y col (2005), las proteínas con la técnica de Bradford (1976) y la actividad de GGTP con el ensayo comercial de Wienner conteniendo Triton X-100. Se utilizó la coloración con HOECHST (1µg/ml) para visualizar apoptosis. Figura-3. Apoptosis en células tratadas con curcumina sin/con sulfato de Cobre.
RESULTADOS
El control no contiene curcumina ni Sulfato de Cobre. En cada barra se ha indicado la desvia-ción estándar de la media. La proliferación celu-lar disminuye significativamente con el trata-miento con curcumina (20 y 40 μM) pero no es afectada por Sulfato de Cobre (2.5 y 10μM) (Figura 1). La curcumina (5 y 10 μM) disminuye la actividad de la enzima GGTP presentando un comportamiento bifásico con un punto de inflexión a los 20 μM de curcumina e incrementa a 40 μM. La adición de Sulfato de Cobre (2.5 μM) no modificó el efecto de la curcumina sin embargo 10 μM provocó un efecto aditivo en la disminución de la actividad de la enzima GGTP (Figura 2). Se observaron figuras apoptóticas ante el tratamiento con curcumina con y sin el agregado de Sulfato de Cobre (Figura 3).
DISCUSIÓN Y CONCLUSIONES
La inhibición en la proliferación y la apoptosis de células ZR-75-1 por la curcumina fue coincidente con Radhakrishna Pillai et al (2004) con células de cáncer de pulmón. En tanto, la disminución de la actividad de GGTP con el incremento de curcumina (5 a 20 µM) y su recuperación a los 40 µM y la potenciación de de la disminución de GGTP frente a 10µM de Sulfato de Cobre, un agente oxidante, no fue observado por otros investigadores. Asì, Farombi et al (2007) encontraron que la GGTP , en testículo de rata, incrementó frente a la curcumina y un agente oxidante y Rukkumani et al (2004) encontraron que el alcohol incrementó la actividad enzimática y no potenció el efecto de la curcumina. Encontramos que la curcumina indujo apoptosis e inhibición de crecimiento de células ZR-75-1 y no presentó un efecto protector frente un oxidante como el Sulfato de Cobre.
